Open Access
Volume 29, 2022
Article Number 35
Number of page(s) 13
Published online 14 July 2022
  1. Adams RL, Bird RJ. 2009. Review article: Coagulation cascade and therapeutics update: relevance to nephrology. Part 1: overview of coagulation, thrombophilias and history of anticoagulants. Nephrology (Carlton), 14, 462–470. [CrossRef] [PubMed] [Google Scholar]
  2. Alves e Silva TL, Radtke A, Balaban A, Pascini TV, Pala ZR, Roth A, Alvarenga PH, Jeong YJ, Olivas J, Ghosh AK, Bui H, Pybus BS, Sinnis P, Jacobs-Lorena M, Vega-Rodríguez J. 2021. The fibrinolytic system enables the onset of Plasmodium infection in the mosquito vector and the mammalian host. Science Advances, 7, eabe3362. [CrossRef] [PubMed] [Google Scholar]
  3. Antoniak S. 2018. The coagulation system in host defense. Research and Practice in Thrombosis and Haemostasis, 2, 549–557. [CrossRef] [PubMed] [Google Scholar]
  4. Arnout J, Hoylaerts MF, Lijnen HR. 2006. Haemostasis. Handbook of Experimental Pharmacology, 176 Pt 2, 1–41. [Google Scholar]
  5. Ayón-Núñez DA, Fragoso G, Bobes RJ, Laclette JP. 2018. Plasminogen-binding proteins as an evasion mechanism of the host’s innate immunity in infectious diseases. Bioscience Reports, 38, BSR20180705. [CrossRef] [PubMed] [Google Scholar]
  6. Baker SK, Strickland S. 2020. A critical role for plasminogen in inflammation. Journal of Experimental Medicine, 217, e20191865. [CrossRef] [PubMed] [Google Scholar]
  7. Balmer EA, Faso C. 2021. The road less traveled? Unconventional protein secretion at parasite-host interfaces. Frontiers in Cell and Developmental Biology, 9, 662711. [CrossRef] [PubMed] [Google Scholar]
  8. Bergmann S, Schoenen H, Hammerschmidt S. 2013. The interaction between bacterial enolase and plasminogen promotes adherence of Streptococcus pneumoniae to epithelial and endothelial cells. International Journal of Medical Microbiology, 303, 452–462. [CrossRef] [PubMed] [Google Scholar]
  9. Butenas S, Mann KG. 2002. Blood coagulation. Biochemistry (Moscow), 67, 3–12. [CrossRef] [Google Scholar]
  10. Cesarman-Maus G, Hajjar KA. 2005. Molecular mechanisms of fibrinolysis. British Journal of Haematology, 129, 307–321. [CrossRef] [PubMed] [Google Scholar]
  11. Chapin JC, Hajjar KA. 2015. Fibrinolysis and the control of blood coagulation. Blood Reviews, 29, 17–24. [CrossRef] [PubMed] [Google Scholar]
  12. Chmelař J, Kotál J, Langhansová H, Kotsyfakis M. 2017. Protease inhibitors in tick saliva: the role of serpins and cystatins in tick-host-pathogen interaction. Frontiers in Cellular and Infection Microbiology, 7, 216. [CrossRef] [PubMed] [Google Scholar]
  13. Combatting anthelmintic resistance in ruminants (COMBAR). 2021. Available at (accessed 19.10.2021). [Google Scholar]
  14. Da’dara AA, de Laforcade AM, Skelly PJ. 2016. The impact of schistosomes and schistosomiasis on murine blood coagulation and fibrinolysis as determined by thromboelastography (TEG). Journal of Thrombosis and Thrombolysis, 41, 671–677. [CrossRef] [PubMed] [Google Scholar]
  15. Eberhard T, Kronvall G, Ullberg M. 1999. Surface bound plasmin promotes migration of Streptococcus pneumoniae through reconstituted basement membranes. Microbial Pathogenesis, 26, 175–181. [CrossRef] [PubMed] [Google Scholar]
  16. Figuera L, Gómez-Arreaza A, Avilán L. 2013. Parasitism in optima forma: exploiting the host fibrinolytic system for invasion. Acta Tropica, 128, 116–123. [CrossRef] [PubMed] [Google Scholar]
  17. Ghosh AK, Coppens I, Gårdsvoll H, Ploug M, Jacobs-Lorena M. 2011. Plasmodium ookinetes coopt mammalian plasminogen to invade the mosquito midgut. Proceedings of the National Academy of Sciences of the United States of America, 108, 17153–17158. [CrossRef] [PubMed] [Google Scholar]
  18. Ginger ML. 2014. Protein moonlighting in parasitic protists. Biochemical Society Transactions, 42, 1734–1739. [CrossRef] [PubMed] [Google Scholar]
  19. Giugliano RP, Wiviott SD, Stone PH, Simon DI, Schweiger MJ, Bouchard A, Leesar MA, Goulder MA, Deitcher SR, McCabe CH, Braunwald E, ANTHEM-TIMI-32 Investigators. 2007. Recombinant nematode anticoagulant protein c2 in patients with non-st-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial. Journal of the American College of Cardiology, 49, 2398–2407. [CrossRef] [PubMed] [Google Scholar]
  20. González-Miguel J, Morchón R, Carretón E, Montoya-Alonso JA, Simón F. 2015. Can the activation of plasminogen/plasmin system of the host by metabolic products of Dirofilaria immitis participate in heartworm disease endarteritis? Parasites & Vectors, 8, 194. [CrossRef] [PubMed] [Google Scholar]
  21. González-Miguel J, Morchón R, Siles-Lucas M, Simón F. 2015. Fibrinolysis and proliferative endarteritis: two related processes in chronic infections? The model of the bood-borne pathogen Dirofilaria immitis. PLoS One, 10, e0124445. [CrossRef] [PubMed] [Google Scholar]
  22. González-Miguel J, Siles-Lucas M, Kartashev V, Morchón R, Simón F. 2016. Plasmin in parasitic chronic infections: friend or foe? Trends in Parasitology, 32, 325–335. [CrossRef] [PubMed] [Google Scholar]
  23. González-Miguel J, Becerro-Recio D, Siles-Lucas M. 2021. Insights into Fasciola hepatica juveniles: crossing the fasciolosis Rubicon. Trends in Parasitology, 37, 35–47. [CrossRef] [PubMed] [Google Scholar]
  24. Hess CN, Capell WH, Bristow MR, Ruf W, Szarek M, Morrow DA, Nicolau JC, Graybill CA, Marshall D, Hsia J, Bonaca MP. 2022. Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial. American Heart Journal, 246, 136–143. [CrossRef] [PubMed] [Google Scholar]
  25. Hewitson JP, Maizels RM. 2014. Vaccination against helminth parasite infections. Expert Review of Vaccines, 13, 473–487. [CrossRef] [PubMed] [Google Scholar]
  26. Jeffery CJ. 1999. Moonlighting proteins. Trends in Biochemical Sciences, 24, 8–11. [CrossRef] [PubMed] [Google Scholar]
  27. Karkowska-Kuleta J, Kozik A. 2014. Moonlighting proteins as virulence factors of pathogenic fungi, parasitic protozoa and multicellular parasites. Molecular Oral Microbiology, 29, 270–283. [CrossRef] [PubMed] [Google Scholar]
  28. Kitt AJ, Leigh JA. 1997. The auxotrophic nature of Streptococcus uberis. The acquisition of essential amino acids from plasmin derived casein peptides. Advances in Experimental Medicine and Biology, 418, 647–650. [CrossRef] [PubMed] [Google Scholar]
  29. Knoll AH, Carroll SB. 1999. Early animal evolution: emerging views from comparative biology and geology. Science, 284, 2129–2137. [CrossRef] [PubMed] [Google Scholar]
  30. Knox DP. 2007. Proteinase inhibitors and helminth parasite infection. Parasite Immunology, 29, 57–71. [PubMed] [Google Scholar]
  31. Kwaan HC, McMahon B. 2009. The role of plasminogen-plasmin system in cancer. Cancer Treatment and Research, 148, 43–66. [CrossRef] [PubMed] [Google Scholar]
  32. Lee A, Agnelli G, Büller H, Ginsberg J, Heit J, Rote W, Vlasuk G, Costantini L, Julian J, Comp P, van Der Meer J, Piovella F, Raskob G, Gent M. 2001. Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation, 104, 74–78. [CrossRef] [PubMed] [Google Scholar]
  33. Lijnen HR. 2001. Elements of the fibrinolytic system. Annals of the New York Academy of Sciences, 936, 226–236. [Google Scholar]
  34. Loeb L, Smith AJ. 1904. The presence of a substance inhibiting the coagulation of blood in the Ancylostoma. Proceedings of the Pathology Society of Philadelphia, 7, 173–178. [Google Scholar]
  35. Ly D, Taylor JM, Tsatsaronis JA, Monteleone MM, Skora AS, Donald CA, Maddocks T, Nizet V, West NP, Ranson M, Walker MJ, McArthur JD, Sanderson-Smith ML. 2014. Plasmin(ogen) acquisition by group A Streptococcus protects against c3b-mediated neutrophil killing. Journal of Innate Immunity, 6, 240–250. [CrossRef] [PubMed] [Google Scholar]
  36. Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, Allen JE. 2004. Helminth parasites – masters of regulation. Immunological Reviews, 201, 89–116. [CrossRef] [PubMed] [Google Scholar]
  37. Maizels RM, McSorley HJ. 2016. Regulation of the host immune system by helminth parasites. Journal of Allergy and Clinical Immunology, 138, 666–675. [CrossRef] [Google Scholar]
  38. Maldonado J, Marina C, Puig J, Maizo Z, Avilan L. 2006. A study of cutaneous lesions caused by Leishmania mexicana in plasminogen-deficient mice. Experimental and Molecular Pathology, 80, 289–294. [CrossRef] [PubMed] [Google Scholar]
  39. Mebius MM, van Genderen PJ, Urbanus RT, Tielens AG, de Groot PG, van Hellemond JJ. 2013. Interference with the host haemostatic system by Schistosomes. PLoS Pathogens, 9, e1003781. [CrossRef] [PubMed] [Google Scholar]
  40. Miles LA, Hawley SB, Baik N, Andronicos NM, Castellino FJ, Parmer RJ. 2005. Plasminogen receptors: the sine qua non of cell surface plasminogen activation. Frontiers in Bioscience, 10, 1754–1762. [PubMed] [Google Scholar]
  41. Molehin AJ, Gobert GN, McManus DP. 2012. Serine protease inhibitors of parasitic helminths. Parasitology, 139, 681–695. [CrossRef] [PubMed] [Google Scholar]
  42. Moons AH, Peters RJ, Bijsterveld NR, Piek JJ, Prins MH, Vlasuk GP, Rote WE, Büller HR. 2003. Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty. Journal of the American College of Cardiology, 41, 2147–2153. [CrossRef] [PubMed] [Google Scholar]
  43. Nicholl SM, Roztocil E, Galaria II, Davies MG. 2005. Plasmin induces smooth muscle cell proliferation. The Journal of Surgical Research, 127, 39–45. [CrossRef] [PubMed] [Google Scholar]
  44. Olson ST, Gettins PG. 2011. Regulation of proteases by protein inhibitors of the serpin superfamily. Progress in Molecular Biology and Translational Science, 99, 185–240. [CrossRef] [PubMed] [Google Scholar]
  45. Othman M, Kaur H. 2017. Thromboelastography (TEG). Methods in Molecular Biology, 1646, 533–543. [CrossRef] [PubMed] [Google Scholar]
  46. Poulin R. 2007. Evolutionary ecology of parasites, 2nd edn. Princeton: Princeton University Press. [CrossRef] [Google Scholar]
  47. Robinson MW, Cwiklinski K. 2021. Proteomics of host-helminth interactions. Pathogens, 10, 1317. [CrossRef] [PubMed] [Google Scholar]
  48. Rojas M, Labrador I, Concepción JL, Aldana E, Avilan L. 2008. Characteristics of plasminogen binding to Trypanosoma cruzi epimastigotes. Acta Tropica, 107, 54–58. [CrossRef] [PubMed] [Google Scholar]
  49. Schmid-Hempel P. 2009. Immune defence, parasite evasion strategies and their relevance for “macroscopic phenomena” such as virulence. Philosophical Transactions of the Royal Society of London Series B Biological Sciences, 364, 85–98. [CrossRef] [PubMed] [Google Scholar]
  50. Sharma A, Kumar G, Sharma S, Walia K, Chouhan P, Mandal B, Tuli A. 2021. Methods for binding analysis of small GTP-binding proteins with their effectors. Methods in Cell Biology, 166, 235–250. [CrossRef] [PubMed] [Google Scholar]
  51. Singh B, Al-Jubair T, Voraganti C, Andersson T, Mukherjee O, Su YC, Zipfel P, Riesbeck K. 2015. Moraxella catarrhalis binds plasminogen to evade host innate immunity. Infection and Immunity, 83, 3458–3469. [CrossRef] [PubMed] [Google Scholar]
  52. Smith SA, Travers RJ, Morrissey JH. 2015. How it all starts: initiation of the clotting cascade. Critical Reviews in Biochemistry and Molecular Biology, 50, 326–336. [CrossRef] [PubMed] [Google Scholar]
  53. Stutzer C, Richards SA, Ferreira M, Baron S, Maritz-Olivier C. 2018. Metazoan parasite vaccines: present status and future prospects. Frontiers in Cellular and Infection Microbiology, 8, 67. [CrossRef] [PubMed] [Google Scholar]
  54. Sumitomo T, Nakata M, Higashino M, Yamaguchi M, Kawabata S. 2016. Group A Streptococcus exploits human plasminogen for bacterial translocation across epithelial barrier via tricellular tight junctions. Scientific Reports, 6, 20069. [CrossRef] [Google Scholar]
  55. Syrovets T, Simmet T. 2004. Novel aspects and new roles for the serine protease plasmin. Cellular and Molecular Life Sciences, 61, 873–885. [CrossRef] [PubMed] [Google Scholar]
  56. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE. 2018. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Annals of Internal Medicine, 169, 467–473. [CrossRef] [PubMed] [Google Scholar]
  57. UniProt. 2021. Available at (accessed 31.01.2022). [Google Scholar]
  58. Van Den Abbeele J, Caljon G, De Ridder K, De Baetselier P, Coosemans M. 2010. Trypanosoma brucei modifies the tsetse salivary composition, altering the fly feeding behavior that favors parasite transmission. PLoS Pathogens, 6, e1000926. [CrossRef] [PubMed] [Google Scholar]
  59. Vieira ML, de Morais ZM, Vasconcellos SA, Romero EC, Nascimento AL. 2011. In vitro evidence for immune evasion activity by human plasmin associated to pathogenic Leptospira interrogans. Microbial Pathogenesis, 51, 360–365. [CrossRef] [PubMed] [Google Scholar]
  60. World Health Organization (WHO). 2021. Available at (accessed 19.10.2021). [Google Scholar]
  61. Zang X, Maizels RM. 2001. Serine proteinase inhibitors from nematodes and the arms race between host and pathogen. Trends in Biochemical Sciences, 26, 191–197. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.